Global Personalized Cancer Medicine Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 309949
  • calendar_today Published On: Jun, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Personalized Cancer Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Personalized Cancer Medicine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Breast Cancer accounting for % of the Personalized Cancer Medicine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Monoclonal Antibodies segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Personalized Cancer Medicine include Abbott, Merck, Novartis, Amgen, and Celgene, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Personalized Cancer Medicine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Monoclonal Antibodies

Personalized Cancer Vaccines

Other

Market segment by Application, can be divided into

Breast Cancer

Lung Cancer

Chronic Myeloid Leukaemia

Bowel Cancer

Other Cancer

Market segment by players, this report covers

Abbott

Merck

Novartis

Amgen

Celgene

Bayer

Roche

Astellas

Astrazeneca

Johnson & Johnson

Agilent

Takeda

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Personalized Cancer Medicine product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Personalized Cancer Medicine, with revenue, gross margin and global market share of Personalized Cancer Medicine from 2019 to 2022.

Chapter 3, the Personalized Cancer Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Personalized Cancer Medicine market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Personalized Cancer Medicine research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Personalized Cancer Medicine

1.2 Classification of Personalized Cancer Medicine by Type

1.2.1 Overview: Global Personalized Cancer Medicine Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Personalized Cancer Medicine Revenue Market Share by Type in 2021

1.2.3 Monoclonal Antibodies

1.2.4 Personalized Cancer Vaccines

1.2.5 Other

1.3 Global Personalized Cancer Medicine Market by Application

1.3.1 Overview: Global Personalized Cancer Medicine Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Breast Cancer

1.3.3 Lung Cancer

1.3.4 Chronic Myeloid Leukaemia

1.3.5 Bowel Cancer

1.3.6 Other Cancer

1.4 Global Personalized Cancer Medicine Market Size & Forecast

1.5 Global Personalized Cancer Medicine Market Size and Forecast by Region

1.5.1 Global Personalized Cancer Medicine Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Personalized Cancer Medicine Market Size by Region, (2017-2022)

1.5.3 North America Personalized Cancer Medicine Market Size and Prospect (2017-2028)

1.5.4 Europe Personalized Cancer Medicine Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Personalized Cancer Medicine Market Size and Prospect (2017-2028)

1.5.6 South America Personalized Cancer Medicine Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Personalized Cancer Medicine Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Personalized Cancer Medicine Market Drivers

1.6.2 Personalized Cancer Medicine Market Restraints

1.6.3 Personalized Cancer Medicine Trends Analysis

2 Company Profiles

2.1 Abbott

2.1.1 Abbott Details

2.1.2 Abbott Major Business

2.1.3 Abbott Personalized Cancer Medicine Product and Solutions

2.1.4 Abbott Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Abbott Recent Developments and Future Plans

2.2 Merck

2.2.1 Merck Details

2.2.2 Merck Major Business

2.2.3 Merck Personalized Cancer Medicine Product and Solutions

2.2.4 Merck Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Merck Recent Developments and Future Plans

2.3 Novartis

2.3.1 Novartis Details

2.3.2 Novartis Major Business

2.3.3 Novartis Personalized Cancer Medicine Product and Solutions

2.3.4 Novartis Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Novartis Recent Developments and Future Plans

2.4 Amgen

2.4.1 Amgen Details

2.4.2 Amgen Major Business

2.4.3 Amgen Personalized Cancer Medicine Product and Solutions

2.4.4 Amgen Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Amgen Recent Developments and Future Plans

2.5 Celgene

2.5.1 Celgene Details

2.5.2 Celgene Major Business

2.5.3 Celgene Personalized Cancer Medicine Product and Solutions

2.5.4 Celgene Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Celgene Recent Developments and Future Plans

2.6 Bayer

2.6.1 Bayer Details

2.6.2 Bayer Major Business

2.6.3 Bayer Personalized Cancer Medicine Product and Solutions

2.6.4 Bayer Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Bayer Recent Developments and Future Plans

2.7 Roche

2.7.1 Roche Details

2.7.2 Roche Major Business

2.7.3 Roche Personalized Cancer Medicine Product and Solutions

2.7.4 Roche Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Roche Recent Developments and Future Plans

2.8 Astellas

2.8.1 Astellas Details

2.8.2 Astellas Major Business

2.8.3 Astellas Personalized Cancer Medicine Product and Solutions

2.8.4 Astellas Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Astellas Recent Developments and Future Plans

2.9 Astrazeneca

2.9.1 Astrazeneca Details

2.9.2 Astrazeneca Major Business

2.9.3 Astrazeneca Personalized Cancer Medicine Product and Solutions

2.9.4 Astrazeneca Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Astrazeneca Recent Developments and Future Plans

2.10 Johnson & Johnson

2.10.1 Johnson & Johnson Details

2.10.2 Johnson & Johnson Major Business

2.10.3 Johnson & Johnson Personalized Cancer Medicine Product and Solutions

2.10.4 Johnson & Johnson Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Johnson & Johnson Recent Developments and Future Plans

2.11 Agilent

2.11.1 Agilent Details

2.11.2 Agilent Major Business

2.11.3 Agilent Personalized Cancer Medicine Product and Solutions

2.11.4 Agilent Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Agilent Recent Developments and Future Plans

2.12 Takeda

2.12.1 Takeda Details

2.12.2 Takeda Major Business

2.12.3 Takeda Personalized Cancer Medicine Product and Solutions

2.12.4 Takeda Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Takeda Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Personalized Cancer Medicine Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Personalized Cancer Medicine Players Market Share in 2021

3.2.2 Top 10 Personalized Cancer Medicine Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Personalized Cancer Medicine Players Head Office, Products and Services Provided

3.4 Personalized Cancer Medicine Mergers & Acquisitions

3.5 Personalized Cancer Medicine New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Personalized Cancer Medicine Revenue and Market Share by Type (2017-2022)

4.2 Global Personalized Cancer Medicine Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Personalized Cancer Medicine Revenue Market Share by Application (2017-2022)

5.2 Global Personalized Cancer Medicine Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Personalized Cancer Medicine Revenue by Type (2017-2028)

6.2 North America Personalized Cancer Medicine Revenue by Application (2017-2028)

6.3 North America Personalized Cancer Medicine Market Size by Country

6.3.1 North America Personalized Cancer Medicine Revenue by Country (2017-2028)

6.3.2 United States Personalized Cancer Medicine Market Size and Forecast (2017-2028)

6.3.3 Canada Personalized Cancer Medicine Market Size and Forecast (2017-2028)

6.3.4 Mexico Personalized Cancer Medicine Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Personalized Cancer Medicine Revenue by Type (2017-2028)

7.2 Europe Personalized Cancer Medicine Revenue by Application (2017-2028)

7.3 Europe Personalized Cancer Medicine Market Size by Country

7.3.1 Europe Personalized Cancer Medicine Revenue by Country (2017-2028)

7.3.2 Germany Personalized Cancer Medicine Market Size and Forecast (2017-2028)

7.3.3 France Personalized Cancer Medicine Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Personalized Cancer Medicine Market Size and Forecast (2017-2028)

7.3.5 Russia Personalized Cancer Medicine Market Size and Forecast (2017-2028)

7.3.6 Italy Personalized Cancer Medicine Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Personalized Cancer Medicine Revenue by Type (2017-2028)

8.2 Asia-Pacific Personalized Cancer Medicine Revenue by Application (2017-2028)

8.3 Asia-Pacific Personalized Cancer Medicine Market Size by Region

8.3.1 Asia-Pacific Personalized Cancer Medicine Revenue by Region (2017-2028)

8.3.2 China Personalized Cancer Medicine Market Size and Forecast (2017-2028)

8.3.3 Japan Personalized Cancer Medicine Market Size and Forecast (2017-2028)

8.3.4 South Korea Personalized Cancer Medicine Market Size and Forecast (2017-2028)

8.3.5 India Personalized Cancer Medicine Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Personalized Cancer Medicine Market Size and Forecast (2017-2028)

8.3.7 Australia Personalized Cancer Medicine Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Personalized Cancer Medicine Revenue by Type (2017-2028)

9.2 South America Personalized Cancer Medicine Revenue by Application (2017-2028)

9.3 South America Personalized Cancer Medicine Market Size by Country

9.3.1 South America Personalized Cancer Medicine Revenue by Country (2017-2028)

9.3.2 Brazil Personalized Cancer Medicine Market Size and Forecast (2017-2028)

9.3.3 Argentina Personalized Cancer Medicine Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Personalized Cancer Medicine Revenue by Type (2017-2028)

10.2 Middle East & Africa Personalized Cancer Medicine Revenue by Application (2017-2028)

10.3 Middle East & Africa Personalized Cancer Medicine Market Size by Country

10.3.1 Middle East & Africa Personalized Cancer Medicine Revenue by Country (2017-2028)

10.3.2 Turkey Personalized Cancer Medicine Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Personalized Cancer Medicine Market Size and Forecast (2017-2028)

10.3.4 UAE Personalized Cancer Medicine Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Personalized Cancer Medicine Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Personalized Cancer Medicine Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Personalized Cancer Medicine Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Personalized Cancer Medicine Revenue (USD Million) by Region (2017-2022)

Table 5. Global Personalized Cancer Medicine Revenue Market Share by Region (2023-2028)

Table 6. Abbott Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Major Business

Table 8. Abbott Personalized Cancer Medicine Product and Solutions

Table 9. Abbott Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Merck Corporate Information, Head Office, and Major Competitors

Table 11. Merck Major Business

Table 12. Merck Personalized Cancer Medicine Product and Solutions

Table 13. Merck Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Novartis Corporate Information, Head Office, and Major Competitors

Table 15. Novartis Major Business

Table 16. Novartis Personalized Cancer Medicine Product and Solutions

Table 17. Novartis Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Amgen Corporate Information, Head Office, and Major Competitors

Table 19. Amgen Major Business

Table 20. Amgen Personalized Cancer Medicine Product and Solutions

Table 21. Amgen Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Celgene Corporate Information, Head Office, and Major Competitors

Table 23. Celgene Major Business

Table 24. Celgene Personalized Cancer Medicine Product and Solutions

Table 25. Celgene Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Bayer Corporate Information, Head Office, and Major Competitors

Table 27. Bayer Major Business

Table 28. Bayer Personalized Cancer Medicine Product and Solutions

Table 29. Bayer Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Roche Corporate Information, Head Office, and Major Competitors

Table 31. Roche Major Business

Table 32. Roche Personalized Cancer Medicine Product and Solutions

Table 33. Roche Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Astellas Corporate Information, Head Office, and Major Competitors

Table 35. Astellas Major Business

Table 36. Astellas Personalized Cancer Medicine Product and Solutions

Table 37. Astellas Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Astrazeneca Corporate Information, Head Office, and Major Competitors

Table 39. Astrazeneca Major Business

Table 40. Astrazeneca Personalized Cancer Medicine Product and Solutions

Table 41. Astrazeneca Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 43. Johnson & Johnson Major Business

Table 44. Johnson & Johnson Personalized Cancer Medicine Product and Solutions

Table 45. Johnson & Johnson Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Agilent Corporate Information, Head Office, and Major Competitors

Table 47. Agilent Major Business

Table 48. Agilent Personalized Cancer Medicine Product and Solutions

Table 49. Agilent Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Takeda Corporate Information, Head Office, and Major Competitors

Table 51. Takeda Major Business

Table 52. Takeda Personalized Cancer Medicine Product and Solutions

Table 53. Takeda Personalized Cancer Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Global Personalized Cancer Medicine Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 55. Global Personalized Cancer Medicine Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 56. Breakdown of Personalized Cancer Medicine by Company Type (Tier 1, Tier 2 and Tier 3)

Table 57. Personalized Cancer Medicine Players Head Office, Products and Services Provided

Table 58. Personalized Cancer Medicine Mergers & Acquisitions in the Past Five Years

Table 59. Personalized Cancer Medicine New Entrants and Expansion Plans

Table 60. Global Personalized Cancer Medicine Revenue (USD Million) by Type (2017-2022)

Table 61. Global Personalized Cancer Medicine Revenue Share by Type (2017-2022)

Table 62. Global Personalized Cancer Medicine Revenue Forecast by Type (2023-2028)

Table 63. Global Personalized Cancer Medicine Revenue by Application (2017-2022)

Table 64. Global Personalized Cancer Medicine Revenue Forecast by Application (2023-2028)

Table 65. North America Personalized Cancer Medicine Revenue by Type (2017-2022) & (USD Million)

Table 66. North America Personalized Cancer Medicine Revenue by Type (2023-2028) & (USD Million)

Table 67. North America Personalized Cancer Medicine Revenue by Application (2017-2022) & (USD Million)

Table 68. North America Personalized Cancer Medicine Revenue by Application (2023-2028) & (USD Million)

Table 69. North America Personalized Cancer Medicine Revenue by Country (2017-2022) & (USD Million)

Table 70. North America Personalized Cancer Medicine Revenue by Country (2023-2028) & (USD Million)

Table 71. Europe Personalized Cancer Medicine Revenue by Type (2017-2022) & (USD Million)

Table 72. Europe Personalized Cancer Medicine Revenue by Type (2023-2028) & (USD Million)

Table 73. Europe Personalized Cancer Medicine Revenue by Application (2017-2022) & (USD Million)

Table 74. Europe Personalized Cancer Medicine Revenue by Application (2023-2028) & (USD Million)

Table 75. Europe Personalized Cancer Medicine Revenue by Country (2017-2022) & (USD Million)

Table 76. Europe Personalized Cancer Medicine Revenue by Country (2023-2028) & (USD Million)

Table 77. Asia-Pacific Personalized Cancer Medicine Revenue by Type (2017-2022) & (USD Million)

Table 78. Asia-Pacific Personalized Cancer Medicine Revenue by Type (2023-2028) & (USD Million)

Table 79. Asia-Pacific Personalized Cancer Medicine Revenue by Application (2017-2022) & (USD Million)

Table 80. Asia-Pacific Personalized Cancer Medicine Revenue by Application (2023-2028) & (USD Million)

Table 81. Asia-Pacific Personalized Cancer Medicine Revenue by Region (2017-2022) & (USD Million)

Table 82. Asia-Pacific Personalized Cancer Medicine Revenue by Region (2023-2028) & (USD Million)

Table 83. South America Personalized Cancer Medicine Revenue by Type (2017-2022) & (USD Million)

Table 84. South America Personalized Cancer Medicine Revenue by Type (2023-2028) & (USD Million)

Table 85. South America Personalized Cancer Medicine Revenue by Application (2017-2022) & (USD Million)

Table 86. South America Personalized Cancer Medicine Revenue by Application (2023-2028) & (USD Million)

Table 87. South America Personalized Cancer Medicine Revenue by Country (2017-2022) & (USD Million)

Table 88. South America Personalized Cancer Medicine Revenue by Country (2023-2028) & (USD Million)

Table 89. Middle East & Africa Personalized Cancer Medicine Revenue by Type (2017-2022) & (USD Million)

Table 90. Middle East & Africa Personalized Cancer Medicine Revenue by Type (2023-2028) & (USD Million)

Table 91. Middle East & Africa Personalized Cancer Medicine Revenue by Application (2017-2022) & (USD Million)

Table 92. Middle East & Africa Personalized Cancer Medicine Revenue by Application (2023-2028) & (USD Million)

Table 93. Middle East & Africa Personalized Cancer Medicine Revenue by Country (2017-2022) & (USD Million)

Table 94. Middle East & Africa Personalized Cancer Medicine Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Personalized Cancer Medicine Picture

Figure 2. Global Personalized Cancer Medicine Revenue Market Share by Type in 2021

Figure 3. Monoclonal Antibodies

Figure 4. Personalized Cancer Vaccines

Figure 5. Other

Figure 6. Personalized Cancer Medicine Revenue Market Share by Application in 2021

Figure 7. Breast Cancer Picture

Figure 8. Lung Cancer Picture

Figure 9. Chronic Myeloid Leukaemia Picture

Figure 10. Bowel Cancer Picture

Figure 11. Other Cancer Picture

Figure 12. Global Personalized Cancer Medicine Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 13. Global Personalized Cancer Medicine Revenue and Forecast (2017-2028) & (USD Million)

Figure 14. Global Personalized Cancer Medicine Revenue Market Share by Region (2017-2028)

Figure 15. Global Personalized Cancer Medicine Revenue Market Share by Region in 2021

Figure 16. North America Personalized Cancer Medicine Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Europe Personalized Cancer Medicine Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Asia-Pacific Personalized Cancer Medicine Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. South America Personalized Cancer Medicine Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Middle East and Africa Personalized Cancer Medicine Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Personalized Cancer Medicine Market Drivers

Figure 22. Personalized Cancer Medicine Market Restraints

Figure 23. Personalized Cancer Medicine Market Trends

Figure 24. Abbott Recent Developments and Future Plans

Figure 25. Merck Recent Developments and Future Plans

Figure 26. Novartis Recent Developments and Future Plans

Figure 27. Amgen Recent Developments and Future Plans

Figure 28. Celgene Recent Developments and Future Plans

Figure 29. Bayer Recent Developments and Future Plans

Figure 30. Roche Recent Developments and Future Plans

Figure 31. Astellas Recent Developments and Future Plans

Figure 32. Astrazeneca Recent Developments and Future Plans

Figure 33. Johnson & Johnson Recent Developments and Future Plans

Figure 34. Agilent Recent Developments and Future Plans

Figure 35. Takeda Recent Developments and Future Plans

Figure 36. Global Personalized Cancer Medicine Revenue Share by Players in 2021

Figure 37. Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 38. Global Top 3 Players Personalized Cancer Medicine Revenue Market Share in 2021

Figure 39. Global Top 10 Players Personalized Cancer Medicine Revenue Market Share in 2021

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 41. Global Personalized Cancer Medicine Revenue Share by Type in 2021

Figure 42. Global Personalized Cancer Medicine Market Share Forecast by Type (2023-2028)

Figure 43. Global Personalized Cancer Medicine Revenue Share by Application in 2021

Figure 44. Global Personalized Cancer Medicine Market Share Forecast by Application (2023-2028)

Figure 45. North America Personalized Cancer Medicine Sales Market Share by Type (2017-2028)

Figure 46. North America Personalized Cancer Medicine Sales Market Share by Application (2017-2028)

Figure 47. North America Personalized Cancer Medicine Revenue Market Share by Country (2017-2028)

Figure 48. United States Personalized Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Canada Personalized Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Mexico Personalized Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Europe Personalized Cancer Medicine Sales Market Share by Type (2017-2028)

Figure 52. Europe Personalized Cancer Medicine Sales Market Share by Application (2017-2028)

Figure 53. Europe Personalized Cancer Medicine Revenue Market Share by Country (2017-2028)

Figure 54. Germany Personalized Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. France Personalized Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. United Kingdom Personalized Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Russia Personalized Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Italy Personalized Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Asia-Pacific Personalized Cancer Medicine Sales Market Share by Type (2017-2028)

Figure 60. Asia-Pacific Personalized Cancer Medicine Sales Market Share by Application (2017-2028)

Figure 61. Asia-Pacific Personalized Cancer Medicine Revenue Market Share by Region (2017-2028)

Figure 62. China Personalized Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Japan Personalized Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. South Korea Personalized Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. India Personalized Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Southeast Asia Personalized Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Australia Personalized Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. South America Personalized Cancer Medicine Sales Market Share by Type (2017-2028)

Figure 69. South America Personalized Cancer Medicine Sales Market Share by Application (2017-2028)

Figure 70. South America Personalized Cancer Medicine Revenue Market Share by Country (2017-2028)

Figure 71. Brazil Personalized Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Argentina Personalized Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Middle East and Africa Personalized Cancer Medicine Sales Market Share by Type (2017-2028)

Figure 74. Middle East and Africa Personalized Cancer Medicine Sales Market Share by Application (2017-2028)

Figure 75. Middle East and Africa Personalized Cancer Medicine Revenue Market Share by Country (2017-2028)

Figure 76. Turkey Personalized Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Saudi Arabia Personalized Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. UAE Personalized Cancer Medicine Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz